{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:51:03Z","timestamp":1778946663209,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"19","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.vaccine.2014.01.077","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T05:15:44Z","timestamp":1394601344000},"page":"2231-2240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates"],"prefix":"10.1016","volume":"32","author":[{"given":"Regina","family":"Scherlie\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankur","family":"Ajmera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mike","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miles W.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nigel J.","family":"Silman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Kemter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony C.","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2014.01.077_bib0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.4155\/tde.11.80","article-title":"Delivery of antigens used for vaccination \u2013 recent advances and challenges","volume":"2","author":"Scherlie\u00df","year":"2011","journal-title":"Ther Deliv"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0010","series-title":"GIVS: global immunization vision and strategy","author":"WHO","year":"2005"},{"issue":"6","key":"10.1016\/j.vaccine.2014.01.077_bib0015","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s11095-008-9559-6","article-title":"Development of stable influenza vaccine powder formulations: challenges and possibilities","volume":"25","author":"Amorij","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0020","first-page":"11","article-title":"Forced degradation studies: an essential tool for the formulation development of vaccines","volume":"3","author":"Hasija","year":"2013","journal-title":"Vaccine Dev Ther"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.077_bib0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1042\/bj3030147","article-title":"Increased thermal stability of proteins in the presence of amino acids","volume":"303","author":"Taneja","year":"1994","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00423-3","article-title":"Lyophilization and development of solid protein pharmaceuticals","volume":"203","author":"Wang","year":"2000","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0040","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1016\/j.vaccine.2007.06.054","article-title":"Rational design of an influenza subunit vaccine powder with sugar glass technology: preventing conformational changes of haemagglutinin during freezing and freeze-drying","volume":"25","author":"Amorij","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s11095-007-9475-1","article-title":"Pharmaceutical particle engineering via spray drying","volume":"25","author":"Vehring","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0050","first-page":"251","article-title":"Spray-drying of proteins: effects of sorbitol and trehalose on aggregation and FT-IR amide I spectrum of an immunoglobulin","volume":"59","author":"Maury","year":"2005","journal-title":"G. EJPB"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.077_bib0055","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2004.02.027","article-title":"Stability of crystallised and spray-dried lysozyme","volume":"278","author":"Elkordy","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0060","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2010.02.025","article-title":"A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation","volume":"144","author":"Saluja","year":"2010","journal-title":"J Controlled Release"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.077_bib0065","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s11095-006-9191-2","article-title":"Drying-induced variations in physico-chemical properties of amorphous pharmaceuticals and their impact on stability II: stability of a vaccine","volume":"24","author":"Abdul-Fattah","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0070","article-title":"Technologies for the development of thermostable vaccines","author":"Lal","year":"2013","journal-title":"PATH"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0075","series-title":"Respiratory drug delivery","article-title":"Development of a standardized dissolution test for inhalable formulations","author":"Son","year":"2008"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0080","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/bp070462h","article-title":"Current perspectives on stability of drug products during formulation, fill and finish operations","volume":"24","author":"Rathore","year":"2008","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0085","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.copbio.2009.10.006","article-title":"Formulation and manufacturability of biologics","volume":"20","author":"Shire","year":"2009","journal-title":"Curr Opin Biotechnol"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1385\/1-59259-076-4:313","article-title":"Aseptic vial filling","volume":"40","author":"Bhamra","year":"2000","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0095","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.freeradbiomed.2005.09.012","article-title":"Protein modification caused by a high dose of gamma irradiation in cryo-sterilized plasma: protective effects of ascorbate","volume":"40","author":"Zbikowska","year":"2006","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0100","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2307\/3571084","article-title":"Radiation-induced oxidation of protein in aqueous solution","volume":"16","author":"Garrison","year":"1962","journal-title":"Radiat Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0105","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0301-4622(01)00188-0","article-title":"Protection of radiation-induced protein damage by curcumin","volume":"92","author":"Kapoor","year":"2001","journal-title":"Biophys Chem"},{"issue":"11","key":"10.1016\/j.vaccine.2014.01.077_bib0110","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"De Groot","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0115","first-page":"32","article-title":"Stabilising biologics for vaccine production","volume":"9","author":"Scholz","year":"2001","journal-title":"Manufacturing Chemist Pharma"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0120","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/biot.201100494","article-title":"A protein-stabilizing technology for enhanced antibody stability and antibody-binding profiles in a microchip array","volume":"7","author":"Scholz","year":"2012","journal-title":"Biotechnol J"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.077_bib0125","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1369-7021(12)70166-9","article-title":"Nano-coating protects biofunctional materials","volume":"15","author":"Tscheliessnig","year":"2012","journal-title":"Mater Today"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.077_bib0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.biologicals.2009.12.005","article-title":"Approach to the profiling and characterization of influenza vaccine constituents by the combined use of size-exclusion chromatography, gel electrophoresis and mass-spectroscopy","volume":"38","author":"Garcia-Ca\u00f1as","year":"2010","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0135","series-title":"8th World meeting on pharmaceutics, biopharmaceutics and pharmaceutical technology","article-title":"Dry powder formulation of proteins via spray drying","author":"Ajmera","year":"2012"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0140","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1016\/j.vaccine.2013.07.081","article-title":"In vivo evaluation of chitosan as an adjuvant in subcutaneous vaccine formulations","volume":"31","author":"Scherlie\u00df","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0145","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.077_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2567.2001.01224.x","article-title":"Glycyrrhizin enhances interleukin-12 production in peritoneal macrophages","volume":"103","author":"Dai","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0155","first-page":"1","article-title":"Application of deglycosylation and electrophoresis to the quantification of influenza viral haemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in china","author":"Li","year":"2010","journal-title":"Biologics"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0160","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1021\/bm700453x","article-title":"Chitosan as a lipid binder: a langmuir monolayer study of chitosan-lipid interactions","volume":"8","author":"Wydro","year":"2007","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.vaccine.2014.01.077_bib0165","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jps.20104","article-title":"Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation","volume":"93","author":"Maa","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0170","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.powtec.2011.06.024","article-title":"The impact of spray drying outlet temperature on the particle morphology of mannitol","volume":"213","author":"Maas","year":"2011","journal-title":"Powder Tech"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0175","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/jps.20740","article-title":"Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization","volume":"95","author":"Wakankar","year":"2006","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1016\/j.vaccine.2014.01.077_bib0180","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/BF02980247","article-title":"Effects of sugar additives on protein stability of recombinant human serum albumin during lyophilization and storage","volume":"30","author":"Han","year":"2007","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0185","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1063\/1.1759615","article-title":"Preferential hydration and the exclusion of cosolvents from protein surfaces","volume":"121","author":"Shimizu","year":"2004","journal-title":"J Chem Phys"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0190","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/prot.22103","article-title":"Structural thermodynamics of protein preferential solvation: osmolyte solvation of proteins, amino acids, and peptides","volume":"73","author":"Auton","year":"2008","journal-title":"Proteins"},{"issue":"4","key":"10.1016\/j.vaccine.2014.01.077_bib0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1021\/js960182o","article-title":"Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers","volume":"86","author":"Aspden","year":"1997","journal-title":"J Pharm Sci"},{"issue":"13","key":"10.1016\/j.vaccine.2014.01.077_bib0200","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2165\/00003088-200342130-00003","article-title":"Absorption enhancers for nasal drug delivery","volume":"42","author":"Davis","year":"2003","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"10.1016\/j.vaccine.2014.01.077_bib0205","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1023\/A:1018901302450","article-title":"Chitosan as a novel nasal delivery system for peptide drugs","volume":"11","author":"Illum","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2014.01.077_bib0215","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/j.1875-9114.1998.tb03127.x","article-title":"Influenza vaccination and warfarin anticoagulation: a comparison of subcutaneous and intramuscular routes of administration in elderly men","volume":"18","author":"Delafuente","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0220","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.vaccine.2004.06.049","article-title":"A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats","volume":"23","author":"Huang","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2014.01.077_bib0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0264-410X(95)00174-Y","article-title":"Antibody responses in volunteers induced by nasal influenza vaccine combined with Escherichia coli heat-labile enterotoxin B subunit containing a trace amount of the holotoxin","volume":"14","author":"Hashigucci","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0230","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9071(200005)61:1<100::AID-JMV16>3.0.CO;2-5","article-title":"Local and systemic immune response in community-dwelling elderly after intranasal or intramuscular immunization with inactivated influenza vaccine","volume":"61","author":"Muszkat","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0235","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/0264-410X(95)00016-T","article-title":"Human immune responses to influenza virus vaccine administered by mucosal or systemic routes","volume":"11","author":"Moldoveanu","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0240","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1016\/S0264-410X(03)00224-X","article-title":"Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus","volume":"21","author":"Smith","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0245","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N Engl J Med"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2014.01.077_bib0250","first-page":"840","article-title":"Protection of cattle against rinderpest by intranasal immunisation with a dry powder tissue culture vaccine","volume":"19","author":"Anderson","year":"2001","journal-title":"Vaccine"},{"issue":"13\u201314","key":"10.1016\/j.vaccine.2014.01.077_bib0255","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/S0264-410X(98)00438-1","article-title":"Dry powder inhalation as a potential delivery method for vaccines","volume":"17","author":"LiCalsi","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0260","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/pats.200409-046TA","article-title":"Deposition of inhaled particles in the human respiratory tract and consequences for regional targeting in respiratory drug delivery","volume":"1","author":"Heyder","year":"2004","journal-title":"Proc Am Thrac Soc"},{"key":"10.1016\/j.vaccine.2014.01.077_bib0265","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/17425247.1.1.67","article-title":"Dry powder inhalers for pulmonary drug delivery","volume":"1","author":"Frijlink","year":"2004","journal-title":"Expert Opin Drug Deliv"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14001406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T23:15:20Z","timestamp":1716592520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14001406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":53,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0264410X14001406"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Induction of protective immunity against H1N1 influenza A(H1N1)pdm09 with spray-dried and electron-beam sterilised vaccines in non-human primates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.01.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}